Subcutaneous metastasis as the first manifestation of a solid-pseudopapillary tumor of the pancreas.
Arias de la Vega
F
F
Service of Radiation Oncology, Hospital of Navarre, Pamplona, Spain. fariasde@cfnavarra.es
Gómez Dorronsoro
M L
ML
Jiménez
F J
FJ
D018262:Adenocarcinoma, Clear Cell / Q000175:diagnosis; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001132:Arm; D015415:Biomarkers / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D003951:Diagnostic Errors; D005260:Female; D006801:Humans; D007633:Keratins / Q000032:analysis; D009363:Neoplasm Proteins / Q000032:analysis; D015260:Neprilysin / Q000032:analysis; D018358:Neuroendocrine Tumors / Q000737:chemistry / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D010751:Phosphopyruvate Hydratase / Q000032:analysis; D012983:Soft Tissue Neoplasms / Q000737:chemistry / Q000556:secondary*; D040521:Subcutaneous Tissue / Q000473:pathology*; D014746:Vimentin / Q000032:analysis; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D015415:Biomarkers; D014408:Biomarkers, Tumor; C400901:CAM 5.2 antigen; D009363:Neoplasm Proteins; D014746:Vimentin; D003841:Deoxycytidine; D007633:Keratins; D015260:Neprilysin; D010751:Phosphopyruvate Hydratase; D000093542:Gemcitabine